Excess Matters

Tag: estrogen

  • Fast Like a Girl by Mindy Pelz: Summary, Key Ideas & Review

    The book in one sentence: Women’s fasting keeps failing not because women are doing it wrong, but because the protocols were designed for men. Mindy Pelz builds the first practical system calibrated to the monthly hormonal cycle that actually governs women’s metabolism.

    What Is Fast Like a Girl About?

    Picture this: you’ve done everything right. You’ve tried 16:8. You’ve tracked macros, cut sugar, done the whole low-carb thing. Your male colleague loses 15 pounds in six weeks on the same protocol. You gain two. Then your period disappears. Then your hair starts falling out. Then you decide fasting just doesn’t “work for you.”

    Mindy Pelz spent years watching this exact scenario play out across her functional medicine practice and YouTube channel. Her explanation is blunt: the fasting research that shaped mainstream advice was conducted almost entirely on men. The 16:8 schedule, the uniform daily eating window, the “just stay consistent” mantra: all of it was calibrated to a body operating on a 24-hour hormonal cycle. Women don’t. Women’s hormones run on a monthly rhythm, and every fasting protocol that ignores that rhythm will eventually backfire.

    Pelz is a chiropractor, not an endocrinologist. Worth noting, and worth keeping in mind as you read. She synthesizes real research (Nobel Prize-winning autophagy science, Valter Longo’s immune-reset fasting studies, peer-reviewed work on insulin and estrogen) and extends it into a practical framework she calls the Fasting Cycle: a month-long system that matches fasting length and eating style to the hormonal phase of the menstrual cycle. The framework is her real contribution, and it’s more useful than most of what the mainstream fasting conversation has produced.

    Why Does Fasting Work Differently for Women?

    The short answer is hormones. The longer answer involves a cascading relationship between four of them: Oxytocin → Cortisol → Insulin → Sex Hormones.

    When cortisol spikes (from stress, overtraining, poor sleep, or fasting at the wrong point in the cycle), it triggers insulin secretion. Elevated insulin then suppresses estrogen and progesterone. A woman can follow a technically correct fasting schedule and still see no improvement if cortisol is chronically high. This is why the woman who “does everything right” and still sees no results isn’t broken. Her protocol is breaking her.

    The top of this hierarchy is oxytocin, which Pelz calls the “love hormone.” It’s produced by hugging, meaningful conversation, laughter, petting animals, yoga, sex. Oxytocin directly calms cortisol. That makes the “soft” stuff (rest, pleasure, connection) physiologically upstream of every hormonal outcome. For the overextended, hard-charging woman who responds to a health plateau by adding more discipline and less food, this is the structural argument that the approach itself is the problem.

    Pelz also takes aim at the Failed Five, the five ways conventional diets actively damage female hormonal health:

    • Calorie restriction raises cortisol, which spikes insulin, which suppresses estrogen and progesterone. The deficit that’s supposed to solve weight is suppressing the hormones that regulate metabolism.
    • Poor food quality (industrial seed oils, refined sugars, endocrine-disrupting chemicals) dysregulates hormonal signaling at the cellular level.
    • Chronic cortisol from overtraining, stress, and aggressive fasting during hormonally sensitive phases keeps the whole sex hormone cascade suppressed.
    • Toxic load from roughly 1,000 endocrine-disrupting chemicals in the modern environment interferes with hormone receptor sites directly.
    • One-size-fits-all protocols ignore the monthly rhythm that governs every metabolic process in a woman’s body.

    “Most diets have blindly disconnected you from your body’s design, leading you straight into the arms of frustration, self-doubt, and distrust with your body.”

    This chapter is the one many women have needed to read for a decade. It relocates failure from the woman to the protocol.

    How Does the Fasting Cycle Actually Work?

    The Fasting Cycle divides the menstrual cycle into three phases, each with distinct fasting and eating recommendations. The logic is anchored in what each sex hormone actually needs to function.

    Phase 1: The Power Phase (Days 1-10 and 16-19)

    Estrogen and other sex hormones are at their lowest during these windows. This is when fasting is most beneficial and best tolerated. All six fasting lengths are appropriate here. Estrogen production prefers a low-insulin environment, which fasting creates. Eating during this phase follows what Pelz calls “ketobiotic” principles: maximum 50 grams net carbs from vegetables, maximum 75 grams protein per day (excess protein triggers gluconeogenesis, blocking ketone production), and 60-plus percent of calories from healthy fats.

    The protein ceiling surprises a lot of women who’ve been told to maximize intake. Pelz is firm: for women in ketosis, the ceiling matters more than the floor.

    Phase 2: The Manifestation Phase (Days 11-15)

    Estrogen and testosterone peak around ovulation. Fasts should stay at 15 hours or under during this window. Here’s why: when estrogen surges, it releases stored toxins from tissues. Autophagy (triggered by 17-plus hour fasts) simultaneously releases toxins from dying cells. Both happening at once produces what Pelz calls a double detox: nausea, brain fog, anxiety, heart palpitations, hair loss. This is the biological explanation for why women feel terrible fasting “correctly” by the conventional 16:8 standard. They’re fasting during ovulation.

    Eating during this phase shifts toward hormone feasting: more liver-supporting foods (cruciferous vegetables, bitter greens, fermented foods) that help clear the estrogen surge rather than let it accumulate.

    Phase 3: The Nurture Phase (Day 20 through the start of the next period)

    No fasting. Progesterone dominates during this phase, and progesterone requires two specific conditions to synthesize: low cortisol and adequate glucose. Fasting elevates cortisol. Strict low-carb eating starves the glucose pathway. Either one during this phase actively depletes progesterone, the hormone responsible for calm, sleep quality, cycle regularity, and emotional stability.

    If your PMS has been getting worse on a keto-plus-fasting protocol, this is the explanation. Up to 150 grams of complex carbohydrates from whole foods (sweet potatoes, lentils, black beans, squash, wild rice, tropical fruits, berries) are not a dietary concession here. They’re the physiological substrate progesterone requires. The strictest dieters often have the worst PMS because they’re removing the very ingredient their body needs for hormonal stability.

    For postmenopausal women, women on hormonal birth control, or anyone without a regular cycle: Pelz provides the 30-Day Fasting Reset, which runs all three phases over 30 days regardless of biological cycle presence. Same logic, applied to a calendar.

    What Are the Six Fasting Lengths and What Does Each One Do?

    One of the book’s genuinely original contributions is the taxonomy of six fasting lengths, each targeting different biological processes at different hour thresholds.

    • 12-16 hours (Intermittent Fasting): Metabolic baseline. Improves blood sugar, blood pressure, gut microbiome diversity, insulin sensitivity. Entry point.
    • 17-72 hours (Autophagy Fasting): Cellular self-cleaning. Dr. Yoshinori Ohsumi’s Nobel Prize-winning research showed that cells, in the absence of food, eat their own damaged organelles and proteins rather than getting weaker. Most relevant for ovarian health (the thecal cells surrounding follicles), brain health (neurons and mitochondria), and immune function.
    • 24+ hours (Gut-Reset Fast): First length to release stem cells into the gut’s mucosal lining. Useful after antibiotics, hormonal birth control use, or for addressing SIBO or leaky gut.
    • 36+ hours (Fat-Burner Fast): Forces the liver to release stored glycogen. Used for women with weight-loss resistance who have plateaued on shorter fasts.
    • 48+ hours (Dopamine-Reset Fast): Repairs and sensitizes dopamine receptors. Effects show up in the weeks following the fast, not during it: reduced compulsive behavior, improved mood, greater contentment.
    • 72 hours (Immune-Reset Fast): Triggers stem cell regeneration of white blood cells. Valter Longo’s research on chemotherapy patients documented that three days of water fasting causes old, depleted white blood cells to die off and a new population to form.

    The practical implication is that fasting length is a clinical decision, not just a willpower variable. Different lengths address different conditions. Choosing how long to fast matters as much as whether to fast at all.

    A caveat worth making explicit: Pelz’s specific hour thresholds (autophagy at exactly 17 hours, immune reset at exactly 72) are more aspirational than evidence-based. The general principle (different fasting lengths trigger different biological processes) holds up. The precise timing markers extend beyond what published research has demonstrated in human subjects. Pelz is synthesizing real science into an accessible framework, but she doesn’t always flag where the clinical evidence ends and practitioner-derived pattern recognition begins.

    Is Fast Like a Girl Worth Reading?

    Read this if you have tried intermittent fasting and experienced adverse effects: hair loss, worsening anxiety, disrupted cycles, no weight loss despite consistent effort. Read it if you’re perimenopausal or postmenopausal and want a structured way to use fasting without amplifying symptoms. Read it if your PMS has been getting worse on a low-carb or fasting protocol and you want to understand why. The cycle-syncing framework alone is worth the read, because it explains patterns that mainstream fasting advice has consistently failed to address.

    Skip it if you have a history of disordered eating or food restriction. The fasting framework here is developed enough that applying it solo, without support, carries real risk for anyone whose relationship with restriction is complicated. Talk to a therapist or registered dietitian first. Also skip it if you need clinical rigor at research-paper depth. Pelz synthesizes well, but she extends beyond the evidence base in places, and her dismissal of calorie restriction as simply one of the “Failed Five” glosses over a substantial body of literature she doesn’t engage with.

    One caveat: The toxic load framework (the claims about environmental chemicals triggering estrogen surges and double-detox symptoms) is more speculative than the fasting science it sits alongside. The core hormonal logic is sound. The more specific mechanistic claims benefit from additional scrutiny. If you’re managing thyroid conditions, type 2 diabetes, or have a complex medication history, involve a physician before applying the condition-specific protocols in Appendix C.

    Books Like Fast Like a Girl

    BookAuthorBest For
    The Circadian CodeSatchin PandaThe research behind time-restricted eating, from one of the scientists who actually ran the studies
    Fast Feast RepeatGin StephensPractical intermittent fasting guide; more accessible, less hormone-specific
    Eat Like a GirlMindy PelzPelz’s follow-up companion focused on the food side of the framework
    The Longevity DietValter LongoThe science behind extended fasting and cellular regeneration; more rigorous, less practical
    The Menopause ResetMindy PelzPelz’s earlier book focused on perimenopause; deeper dive on hormonal transition without the full fasting framework

  • The XX Brain by Lisa Mosconi: Summary, Key Ideas & Review

    Book in one sentence: A neuroscientist who scans brains for a living makes the case that Alzheimer’s is largely preventable in women, if we stop treating women’s brains like smaller male ones.

    What Is The XX Brain About?

    If you’ve ever walked into a room and forgotten why you went there, your doctor probably smiled and said “that happens to everyone.” Maybe it does. But Lisa Mosconi’s research suggests it happens more to women, more often, starting earlier. There’s a measurable biological reason why. She’s not guessing. She’s been scanning women’s brains for two decades at Weill Cornell Medicine, where she’s associate director of the first Alzheimer’s Prevention Clinic in the United States.

    Here’s the statistic she opens with: two-thirds of all Alzheimer’s patients in the U.S. are women. A 60-year-old woman is twice as likely to develop Alzheimer’s in her remaining lifetime as she is to develop breast cancer. Her mother developed it. Her grandmother developed it. She wrote this book because medicine has spent generations treating women’s brains as though they were simply smaller male brains, and the consequences of that assumption are now showing up in the numbers.

    The XX Brain makes a specific, evidence-backed argument: the brain fog, memory slips, sleep disruption, and mood changes that women experience in perimenopause are not “just aging.” They show up on brain scans. They correspond to real metabolic changes. And they are, in many cases, the earliest detectable signal of Alzheimer’s risk (occurring 20 to 30 years before anyone would ever be diagnosed). The good news buried inside that alarming fact is that the window for doing something about it is long, and most of the interventions are free.

    Why Do Women Get Alzheimer’s at Twice the Rate?

    The standard answer is that women live longer. Mosconi’s answer is: that’s not the whole story.

    Women carry a distinct Alzheimer’s vulnerability that has nothing to do with longevity and everything to do with biology. Women are more likely to carry the APOE-4 gene variant (the main genetic risk factor for Alzheimer’s). They’re more likely to develop tau pathology. Their hippocampuses (the brain’s memory center) atrophy faster once the disease begins. And because women’s verbal memory systems are so strong, early Alzheimer’s pathology can be masked for years while it accumulates silently.

    There’s also a myth Mosconi dismantles cleanly: Alzheimer’s is not genetic destiny. Only 1-2% of cases come from rare deterministic mutations. For the remaining 98%, risk is built from a combination of genetics, hormones, medical history, and daily choices over decades. APOE-4 is a susceptibility factor, not a sentence. The modifiable risks (cardiovascular disease, type 2 diabetes, obesity, hypertension, chronic stress, sleep deprivation, poor diet) account for a substantial share of Alzheimer’s cases. Every one of them is addressable.

    The hard part is timing. By the time someone gets an Alzheimer’s diagnosis, pathology has been accumulating for two or three decades. The brain scan changes Mosconi’s lab detects in perimenopausal women (reduced glucose metabolism in memory and reasoning centers) look strikingly similar to what they see in early Alzheimer’s. That’s not a reason to panic. It’s a reason to act in your 40s, not your 70s.

    What Does Estrogen Actually Do in the Brain?

    Most people think of estrogen as a reproductive hormone. That framing is wrong, and Mosconi spends the first quarter of the book correcting it.

    Estrogen is a neurological hormone. Estrogen receptors are distributed throughout the brain: the hippocampus, prefrontal cortex, amygdala, and brainstem. Through those receptors, estrogen governs how the brain fuels itself, manages inflammation, builds new synaptic connections, and regulates serotonin, GABA, and endorphins. Mosconi calls it the brain’s “master regulator.” When it declines during perimenopause, the brain’s energy supply falters and its defenses weaken.

    “Estrogen is a ‘master regulator’ in the female brain, serving many roles that actually have nothing to do with reproduction, but rather everything to do with energy.”

    This reframe matters because it changes how to interpret what’s happening during the menopausal transition. Perimenopause is not just a reproductive event. It’s a neurological one. The brain fog is real. The memory lapses are real. The mood volatility is real. These are not character flaws or signs that you’re “losing it.” They’re measurable metabolic changes that show up on imaging.

    Mosconi also takes on the hormone therapy mess left by the 2002 Women’s Health Initiative trials, which spooked a generation of women and doctors away from menopausal hormone therapy (MHT). The WHI studied women averaging 63 years old (more than a decade past menopause) given synthetic progestins and conjugated equine estrogen derived from pregnant mares. The results were applied to all women, everywhere, forever. That was the error. The “timing hypothesis,” supported by substantial research since, holds that MHT begun during perimenopause or early menopause (when estrogen receptors are still active) carries a very different risk profile. Women who start it in that window show reduced cardiovascular risk, preserved cognitive function, and in several studies, reduced Alzheimer’s risk. Transdermal estradiol and micronized progesterone carry less risk than the formulations studied in the WHI. Mosconi isn’t telling every woman to take hormones. She’s giving women enough information to have a real conversation with their doctor.

    What Should Women Actually Eat for Brain Health?

    Mosconi is a neuroscientist who studies diet and the brain, so her nutrition chapter is grounded in actual research rather than the usual “eat whole foods” non-advice. The framework is built on Mediterranean and MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet research, with adjustments specific to women’s hormonal and metabolic needs.

    The headline findings:

    • Dark leafy greens, daily. One serving per day is associated with cognitive function 11 years younger than in women who rarely eat them. The active components are vitamins K, folate, and lutein.
    • Berries, twice a week. Blueberries and strawberries specifically, based on a 16,000-woman study showing 2.5 years of slower cognitive aging with two or more weekly servings. Flavonoids are the mechanism.
    • Fatty fish, 2-3 times a week. Omega-3s (EPA and DHA) are critical for brain membrane structure and anti-inflammatory signaling. Low omega-3 index in women predicts accelerated cognitive aging.
    • Fiber, 25+ grams daily. Women’s estrogen metabolism depends on gut bacteria that require adequate fiber. Fiber also stabilizes blood glucose, which directly reduces brain inflammation.
    • Olive oil as primary fat. The Mediterranean-MIND trials with the strongest cognitive outcome data all center on olive oil.

    The surprises are what to cut. Refined grains, added sugar, ultra-processed food: expected. Alcohol is the one that lands differently. Even one drink per day is associated with measurable brain shrinkage in women. The “a glass of wine is protective” narrative does not hold up in neuroimaging research. Mosconi doesn’t moralize about it; she just reports what the scans show.

    On exercise: 40 minutes of brisk walking three times per week grew hippocampal volume by 2% in one year in a clinical trial she cites (Kirk Erickson’s 2011 study). The stretching-only control group showed the normal 1-2% annual brain shrinkage. Walking as if late for a meeting, three times a week, rolled back cognitive age by approximately two years. No gym, no equipment, no elite fitness required.

    Sleep and stress get real treatment too. Chronic cortisol exposure damages brain tissue. Seven to nine hours of sleep is when the glymphatic system flushes amyloid and tau (the proteins that cause Alzheimer’s). Social isolation is an independent Alzheimer’s risk factor of similar magnitude to cardiovascular disease. Scheduling time with friends is, by this research, a legitimate brain health intervention.

    Is The XX Brain Worth Reading?

    Read this if you’re a woman in your 30s, 40s, or 50s who wants to understand what’s actually happening in your brain as your hormones shift. If you’ve ever been dismissed when reporting brain fog, memory issues, or mood disruption around perimenopause. If you have a maternal family history of Alzheimer’s and want a concrete prevention framework. If you’ve avoided or feel confused about hormone therapy because of the 2002 WHI scare.

    Skip it if you want a quick-read checklist with no science. Mosconi writes for an educated general audience, but this is not a 10-minute skim. She is translating FDG-PET imaging and genomic research into plain language, and that takes some patience.

    One caveat: Published in 2020, so the MHT and APOE-4 research landscape has continued to move. Readers with specific questions about hormone therapy should check current clinical guidelines alongside this book, not instead of them. Mosconi’s follow-up, The Menopause Brain (2024), deepens the hormonal transition content with more recent data.

    Books Like The XX Brain

    BookAuthorBest For
    The Menopause BrainLisa MosconiMosconi’s 2024 follow-up focused on the menopausal transition specifically
    Brain FoodLisa MosconiHer 2018 book with deeper nutritional science for brain health
    Brain Body DietSara Gottfried, MDHormonal drivers of women’s brain and metabolic health
    The Menopause ManifestoJen Gunter, MDEvidence-based guide to menopause without the fear
    Hormone IntelligenceAviva Romm, MDIntegrative approach to women’s hormonal health across the lifespan

  • The XX Brain by Lisa Mosconi: Review, Key Ideas & What Actually Matters for Women’s Brain Health

    Why This Book Exists — and Why It Matters

    Here is a statistic that should be front-page news: two-thirds of all Alzheimer’s patients in the United States are women. A 60-year-old woman is twice as likely to develop Alzheimer’s in her remaining lifetime as she is to develop breast cancer. Women make up the overwhelming majority of unpaid dementia caregivers. And yet, for most of medical history, Alzheimer’s research was conducted primarily on men, using male-derived norms, with findings generalized to everyone.

    Lisa Mosconi is Director of the Women’s Brain Initiative at Weill Cornell Medical College and Associate Director of the first Alzheimer’s Prevention Clinic in the United States. She has been scanning women’s brains for two decades. Her mother and grandmother both developed Alzheimer’s. She is not writing as an outsider to this topic — she is writing from the inside of a crisis that medicine has systematically underaddressed.

    The XX Brain is her answer to a simple but devastating question: why are women’s brains so disproportionately affected by Alzheimer’s, and what can we actually do about it? Her answer is grounded in neuroimaging data, clinical trials, genomic research, and 20 years of patient care. This is not a wellness book dressed in science language. It is science, translated into something a woman can actually use.

    For anyone who has ever been told that brain fog, memory lapses, mood changes, or cognitive symptoms are “just aging” or “just hormones” — this book is a direct refutation of that dismissal.

    The Core Argument: Estrogen Is a Brain Hormone

    The single most important idea in The XX Brain is also the one most consistently overlooked by medicine: estrogen is not primarily a reproductive hormone. It is a neurological hormone that happens to also govern reproduction.

    Estrogen receptors are distributed throughout the brain — in the hippocampus (memory), the prefrontal cortex (reasoning and planning), the amygdala (emotional processing), and beyond. Through those receptors, estrogen governs the brain’s energy metabolism, neuroprotective immune function, production of new synaptic connections, and release of serotonin, GABA, and endorphins. Mosconi describes estrogen as the brain’s “master regulator” — and the data backs this up.

    This reframe matters enormously because it changes how we interpret what happens at menopause. Menopause is not merely the end of reproductive capacity. It is a neurological event. When estrogen declines, the brain’s energy supply falters, its inflammatory defenses weaken, and the infrastructure for memory and mood is compromised. The brain fog, sleep disruption, mood volatility, and memory lapses of perimenopause are not psychosomatic. Mosconi’s own FDG-PET imaging shows reduced brain glucose metabolism in perimenopausal women — the same metabolic signature seen in early Alzheimer’s disease — years before any clinical symptoms appear.

    This is the foundation everything else is built on. Understanding that estrogen is a brain hormone makes the rest of the book’s recommendations not optional lifestyle tips, but medically justified interventions.

    The Alzheimer’s Myth That Keeps Women Helpless

    Before Mosconi gets to solutions, she clears away a lie that has kept women passive about their brain health: the idea that Alzheimer’s is genetic destiny.

    Deterministic Alzheimer’s — caused by rare genetic mutations (PSEN1, PSEN2, APP) — accounts for only 1–2% of all cases. For the other 98–99%, Alzheimer’s is multifactorial: an interaction of genetic susceptibilities, medical conditions, hormonal status, and lifestyle choices that accumulate over decades. APOE-4, the most well-known risk gene, is a susceptibility factor, not a sentence. APOE-4 carriers who maintain an active, well-nourished, low-stress lifestyle dramatically reduce the probability that their genetic risk will actualize.

    Here is the kicker: Alzheimer’s pathology — amyloid plaques, tau tangles — begins accumulating 20 to 30 years before symptoms appear. This is not a reason for despair. It is a reason to act in your 40s, not your 70s. Mosconi’s research shows that brain imaging can detect early metabolic changes at subclinical stages when the brain is still fully capable of responding to intervention. The window for prevention is long, the interventions are real, and waiting for symptoms means waiting too long.

    The modifiable risk factors Mosconi identifies are not exotic. They include cardiovascular disease, type 2 diabetes, obesity, hypertension, depression, sleep deprivation, chronic stress, sedentary lifestyle, and poor diet. Every single one of them is addressable.

    Key Ideas Worth Knowing

    The Critical Window for Hormonal Therapy

    One of the most important — and most misunderstood — sections of the book concerns menopausal hormone therapy (MHT). In 2002–2003, the Women’s Health Initiative trials were halted early after showing that MHT increased risk of stroke, blood clots, and breast cancer. The resulting panic caused 80% of American women using MHT to stop overnight. Doctors stopped prescribing it. A generation of women was left without a tool many would have benefited from, based on findings that were misapplied.

    Mosconi explains what the WHI actually studied: women averaging 63 years old — more than a decade past menopause — given synthetic progestins combined with conjugated equine estrogen (derived from pregnant mares’ urine). The problem is not MHT itself; it is that the WHI used the wrong women, at the wrong time, with the wrong formulation.

    The “timing hypothesis” holds that hormonal therapy initiated during perimenopause or early menopause — when estrogen receptors are still active and responsive — has a fundamentally different risk/benefit profile. Research published since the WHI supports that women who begin MHT within a few years of menopause onset show reduced cardiovascular risk, preserved cognitive function, and in several studies, reduced Alzheimer’s risk. Transdermal estradiol carries significantly less thrombotic risk than oral conjugated equine estrogen. Micronized progesterone is safer than synthetic progestins.

    Mosconi is not telling every woman to take hormones. She is giving women the information to have an actual, informed conversation with their doctor — rather than a reflexive “no” based on a misread study.

    What Actually Happens in the Female Brain at Menopause

    Women’s brains are not smaller male brains. They are structurally and biochemically distinct. The female brain has stronger connectivity between the hippocampus, amygdala, and frontal cortex — producing generally stronger verbal memory, emotional memory integration, and social cognition. Women process emotional information more bilaterally. These are genuine strengths.

    The vulnerability comes from the same source: the female brain is more tightly coupled to hormonal environment. This is why Alzheimer’s presents differently in women. Because verbal memory systems are so robust, early Alzheimer’s pathology can be masked — women compensate, continuing to appear cognitively normal while pathology accumulates. When symptoms do appear, they tend to progress more steeply. Women are also more likely to be APOE-4 carriers, more likely to show tau pathology, and show faster hippocampal atrophy once disease begins.

    None of this was reflected in standard diagnostic norms built on male data. Mosconi’s work — and the growing field of sex-differentiated neurology she is helping to build — is correcting that.

    Diet: The Research Is Specific, Not Vague

    Mosconi does not recommend “eating healthy.” She identifies specific nutrients, specific foods, and specific quantities with clinical trial or large-scale observational study support — and she specifies the evidence for women in particular:

    • Dark leafy greens: One serving daily is associated with cognitive function 11 years younger than age-matched peers who rarely eat them. The mechanism involves vitamins K, folate, and lutein.
    • Berries: Eating at least one serving of blueberries and two servings of strawberries per week was associated with 2.5 years of slower cognitive aging in women (based on a study of 16,000+ women). Flavonoid content is the active component.
    • Fatty fish: Omega-3 fatty acids (EPA/DHA) are critical for brain membrane structure and anti-inflammatory signaling; 2–3 servings weekly is the research target.
    • Fiber: Women’s estrogen metabolism depends on gut bacteria that require adequate fiber for proper estrogen processing; 25+ grams daily stabilizes blood glucose and supports hormonal balance.
    • Olive oil: Primary fat source in Mediterranean-MIND trials with the strongest cognitive outcome data.

    What to limit: refined grains, added sugar, ultra-processed foods, and — this surprises many people — alcohol. Even one drink per day is associated with measurable brain shrinkage in women. The “a glass of wine is protective” narrative does not survive neuroimaging data.

    Exercise Is Brain Architecture

    A clinical trial Mosconi cites had 120 sedentary adults do either brisk walking or yoga/stretching for one year. The stretching group showed the 1–2% brain shrinkage normal for aging. The walkers showed a 2% increase in hippocampal volume and measurable improvement in memory performance — rolling back cognitive age by approximately two years. From walking.

    The mechanism is real: aerobic exercise increases BDNF (brain-derived neurotrophic factor, which promotes neuronal growth and new synaptic connections), reduces systemic inflammation, improves insulin sensitivity, and enhances cerebral blood flow. In APOE-4 carriers, regular exercise measurably reduces amyloid plaque accumulation — meaning genetic Alzheimer’s risk is partially offset by movement.

    The prescription is simple: 40 minutes of brisk walking (walking as if late for an appointment), three times per week. That is it. Not an elite fitness regimen — a sustainable, evidence-based minimum that produces structural brain changes.

    Sleep and Stress Are Not Soft Topics

    Chronic stress elevates cortisol chronically. Chronic cortisol elevation damages brain tissue. A study of 2,000+ middle-aged adults found that high-stress individuals show measurable memory loss and brain shrinkage before age 50 — with effects more severe in women. Women also face specific sleep disruption risks during perimenopause (hot flashes, hormonal fluctuations, heightened anxiety) that require intentional management.

    Sleep is when the brain’s glymphatic system flushes amyloid-beta and tau. Seven to nine hours of quality sleep is not a wellness preference; it is the cleaning cycle for the proteins that cause Alzheimer’s.

    Mosconi also makes an argument that social connection is medically neuroprotective. Social isolation is an independent Alzheimer’s risk factor. Strong friendships, community engagement, and intellectually stimulating relationships reduce risk — and the effect is larger for women than for men. This is not soft advice. It is the tend-and-befriend stress response, documented neurobiologically: women co-release oxytocin with cortisol, orienting toward social connection under stress, and this response is genuinely protective when channeled toward real relationships.

    Notable Quotes

    “Estrogen is a ‘master regulator’ in the female brain, serving many roles that actually have nothing to do with reproduction, but rather everything to do with energy.”

    The thesis of the entire book, in one sentence.

    “Women were promised we could ‘have it all.’ We’ve discovered that means ‘doing it all’ instead. And not only do we now get to do it all, but we do so for lower pay and less recognition, and not at all surprisingly, at the expense of our health.”

    Mosconi locating women’s brain health crisis within a larger social context — the health consequences of overextension are not personal failure, they are systemic.

    “There is a chronic lack of acknowledgment regarding how gender affects our distinct needs and requirements when it comes to adequate nutrition—unless a woman is pregnant, that is.”

    The state of nutritional research for women, bluntly stated.

    “Eating a salad a day can keep your brain younger by as much as eleven years!”

    An extraordinary finding that should be common knowledge and is not.

    “This is a forever plan, not just a quick fix. As with anything of excellence, it takes discipline, consistency, and commitment. The difference is, with this quality of investment in yourself, the benefits will last a lifetime.”

    Mosconi’s honest framing of what prevention actually requires — and why it is worth it.

    Who Should Read This

    Read it if you are:

    • A woman in your 30s, 40s, or 50s who wants to understand what is actually happening in your brain as your hormones shift
    • Anyone experiencing brain fog, memory changes, or mood disruptions around perimenopause who has been told it is “just aging”
    • Someone with a family history of Alzheimer’s — especially maternal history — who wants an evidence-based prevention framework
    • A woman who has avoided or is confused about menopausal hormone therapy based on the 2002 WHI scare
    • Anyone who cares for women and wants to understand their brain health needs

    Skip it (or read selectively) if:

    • You want a quick-read checklist with no science — the book requires engagement with genuinely complex biology
    • You are already deeply versed in neuroimaging research and are looking for primary literature rather than translation

    Read alongside:

    • Brain Food by Lisa Mosconi (2018) — the deeper nutritional science companion
    • Why We Sleep by Matthew Walker — essential on sleep’s role in amyloid clearance
    • The Menopause Brain by Lisa Mosconi (2024) — her updated, focused work on the menopausal transition

    What to Actually Do With This Book

    Mosconi is not presenting a theory. She is presenting an action plan. The core asks are:

    1. Get a basic risk assessment: know your APOE status (23andMe or a clinical test), your homocysteine, your fasting glucose, your blood pressure, your B12, your vitamin D.
    2. Eat the Mediterranean-MIND pattern, with particular attention to dark leafy greens daily, berries twice weekly, fatty fish 2–3x weekly, fiber 25g+ daily.
    3. Walk briskly 40 minutes, three times per week, consistently.
    4. Protect sleep — 7–9 hours, address hormonal sleep disruption, screen for apnea.
    5. Manage stress through social connection (not just alone-time self-care, which is also valuable, but specifically relationships).
    6. Learn something genuinely new — not deepening an existing skill, but building cognitive reserve through novelty.
    7. If you are approaching menopause, have an informed conversation with your doctor about the timing hypothesis and your personal risk/benefit profile for MHT.

    None of this requires a prescription or a genetic test to begin. Most of it is free. All of it is evidence-based.

    Related Reviews on Excess Matters

  • Sex, Lies, and Menopause by T.S. Wiley: Summary, Key Ideas & Review

    Book in one sentence: Wiley argues that synthetic HRT causes harm while bioidentical hormones at high cyclical doses can restore pre-menopausal health. A critique that is partly right and partly dangerous, depending on which half you take seriously.

    What Is Sex, Lies, and Menopause About?

    In 2002, the Women’s Health Initiative stopped its major hormone trial early and set off a global panic. The drug being tested was PremPro (a cocktail of equine estrogen from mares’ urine and a synthetic progestin called medroxyprogesterone acetate). When the trial found elevated rates of breast cancer, heart disease, stroke, and dementia among users, millions of women stopped their hormone prescriptions overnight. Menopause medicine went conservative and stayed there for years.

    T.S. Wiley published this book two years later, arguing that the panic was misguided. The WHI had tested one specific patented drug, and the findings were being applied to all hormone therapy, including bioidentical estradiol and natural progesterone, which are different molecules entirely. That critique, once considered fringe, is now mainstream. The book’s core pharmacological argument has been validated by subsequent research, including the KEEPS trial, the ELITE trial, and a decade of timing-hypothesis literature.

    Here is where things get complicated: Wiley is not a doctor. She holds an anthropology degree. The book is co-authored with an oncologist (Julie Taguchi, M.D.) and a biochemist (Bent Formby, Ph.D.), which lends some credibility to the mechanistic sections. But the clinical conclusions Wiley draws from the science (including her own proprietary “Wiley Protocol”) have been specifically criticized by the FDA, the North American Menopause Society, and the Endocrine Society. Reading this book fairly requires holding two things simultaneously: some of what she says is correct and ahead of its time, and some of it is speculation dressed as certainty. This review will flag which is which.

    What Does Wiley Actually Get Right?

    A lot, as it turns out. At least in the first half of the book.

    The WHI tested the wrong drug for the question being asked. Premarin is not estradiol. It is a mixture of ten different equine estrogens that the human body never encountered in evolution. MPA (synthetic progestin) binds to progesterone, estrogen, and androgen receptors, producing unpredictable effects throughout the body. Natural progesterone binds selectively to progesterone receptors. The PEPI trials, which Wiley cites accurately, found that the arm combining Premarin with natural progesterone had the best cardiovascular outcomes of all arms tested. Natural progesterone cannot be patented, so the finding received no industry follow-up and never became standard practice. The patentability-shapes-research argument is not conspiracy theory; it is well-documented in health policy literature entirely independent of Wiley.

    Estrogen is not a reproductive hormone. It is a systemic maintenance molecule. Wiley’s most compelling passage cites over 300 bodily processes and more than 9,000 gene products that require estrogen to function, none of them directly involved in reproduction. Estrogen governs myelin maintenance in the brain, serotonin transport, GABA receptor sensitivity, insulin response, cardiovascular function, and bone density. When it disappears at menopause, the downstream effects are not incidental. They are predictable.

    The chronobiology section is stronger than readers expect. The mechanism Wiley traces from artificial light at night through melatonin suppression to disrupted estrogen receptor cycling is grounded in established science. Melatonin gates estrogen receptor availability; artificial light chronically suppresses melatonin; without that signal, the monthly estrogen crescendo is blunted. Sleep disruption raises cortisol, drives insulin resistance, and accelerates perimenopausal dysfunction. Treating sleeplessness with a sleep aid while ignoring its hormonal drivers misses the point. Sleep disruption is not just a symptom of hormonal chaos. It feeds back to create more of it.

    The evolutionary framing is also useful here, even if Wiley overextends it later. Human life expectancy at the turn of the 20th century was roughly 48 years for women. Evolution designed a hormonal system for organisms expected to reproduce and die, not for three or four decades of post-reproductive life. Menopause is not a designed second act. The body’s deterioration after estrogen loss is predictable entropy, not natural flourishing. Wiley’s sharpest rhetorical line: Margaret Mead, famous for coining the phrase “postmenopausal zest,” was receiving weekly estrogen injections from midlife until she died. The naturalistic fallacy applied to hormone decline does not survive contact with that fact.

    What Is the Wiley Protocol (and Why Is It Controversial)?

    This is where the book earns its polarized reception.

    The Wiley Protocol is a proprietary compounding system that doses transdermal bioidentical estradiol and progesterone in a rising-and-falling 28-day cycle. The target: replicate the serum hormone levels of a woman aged 15 to 22. Peak estradiol targets are 350 to 500 pg/mL. For context, typical clinical practice targets 20 to 50 pg/mL. That is not a rounding difference. The Protocol requires a monthly withdrawal bleed as evidence that hormone peaks were sufficient, and it is only available through Wiley Registered Pharmacies in branded syringes.

    The theoretical argument for cyclical dosing is sound. Estrogen drives cell proliferation and also, at peak levels, creates the progesterone receptors needed to receive progesterone’s apoptotic (cell-death) signal. Without the estrogen peak, progesterone receptors never appear. Cells remain in chronic low-level growth without the counterweight. Static daily-dose HRT, even bioidentical daily estradiol, does not replicate this cycle. The mechanism for why rhythmic dosing might matter is real. The specific doses the Protocol uses are not validated.

    Here is what the major medical bodies have actually said:

    • The FDA has sent warning letters to compounding pharmacies carrying the Protocol for unapproved drug claims
    • The North American Menopause Society has specifically criticized doses “far above clinical practice norms without safety data”
    • The Endocrine Society has flagged the cancer prevention claims as unproven
    • The “period forever” requirement (inducing monthly uterine lining buildup in postmenopausal women) is considered a potential cancer risk by many clinicians

    No randomized controlled trial has tested the Wiley Protocol’s safety or efficacy. “Bioidentical” describes molecular identity, not dose safety. High doses of natural estradiol still carry risks that do not disappear because the molecule matches what the body produces. Wiley the anthropologist interprets the mechanistic research with a clear agenda and without the epistemic humility that clinical uncertainty requires. The co-authors with actual clinical credentials (Taguchi and Formby) validate the science of individual mechanisms, not the Protocol’s dosing targets.

    The causal chains Wiley builds are also a problem. She links artificial light to breast cancer, anovulatory cycles to Alzheimer’s, sleep disruption to oncogenesis, and autoimmunity to cancer-compensatory antibody production. Each individual link may have some support. The complete chain as a proven causal mechanism does not. The autoimmunity theory in particular (that postmenopausal arthritis and psoriasis are functioning as a Herceptin-equivalent anti-cancer system, and that treating them with steroids removes cancer protection) is intellectually interesting and almost entirely speculative.

    The Hormone-Weight Connection Wiley Makes

    For the ExcessMatters audience, this is the relevant thread to pull.

    Wiley’s perimenopausal model is clinically useful even if her protocol is not. Perimenopause, she argues, is mechanistically analogous to early puberty. In both states: estrogen is low and fluctuating, testosterone is rising (via adrenal drive), FSH is elevated and erratic, sleep is disrupted, insulin resistance appears, and ovulation is absent. The difference is that in puberty the system is building toward the first ovulatory estrogen peak. In perimenopause, there are no eggs left to generate that peak. The loop never completes.

    The result is a body stuck in anovulatory mode: enough estrogen to drive cell growth and hunger signaling, without the progesterone peak to balance it. Insulin resistance climbs. Cortisol stays elevated. The weight gain of perimenopause is not a caloric failure. It is a hormonal environment. Chasing it with restriction tends to raise cortisol further, which makes the insulin resistance worse.

    The chronobiology piece connects here too. Poor sleep raises ghrelin (hunger hormone) and drops leptin (satiety hormone), independently of calories consumed. Perimenopausal sleep disruption is a driver of weight gain through this route, not just a side effect of it. Fixing the sleep environment (light exposure, sleep timing, cortisol management) is a metabolic intervention, not just a wellness recommendation.

    What Wiley gets right on this topic: hormones drive weight in perimenopause, and treating the symptoms without addressing the hormonal environment is incomplete. What she overstates: the specific idea that the Wiley Protocol’s doses are the correct intervention for this, without any clinical trial data to support it.

    Is Sex, Lies, and Menopause Worth Reading?

    Read this if you want to understand the WHI controversy in depth, you’re evaluating hormone therapy options and want the bioidentical/synthetic distinction explained in detail, or you’re interested in the chronobiology of sleep and hormones. Read the first half critically and carefully.

    Skip it if you need clinical guidance on what to actually do about menopause. This book is not a prescription guide, and using it as one carries real risk. For evidence-based HRT guidance, Menopause Bootcamp by Suzanne Gilberg-Lenz is a better starting point. For the mainstream academic defense of hormone therapy (without Wiley’s dosing extremism), Estrogen Matters by Bluming and Tavris covers the same WHI critique with far more evidentiary rigor.

    One caveat: Wiley’s argument that pharmaceutical economics distort which treatments get studied is correct and important. But the conclusion she draws from it (that the Wiley Protocol must therefore be safe because it hasn’t been funded to be studied) is a logical gap wide enough to drive a truck through. The absence of industry funding for a treatment is not evidence of that treatment’s safety. It is evidence of how research funding works.

    The book’s most honest summary may be this: the difference between bioidentical and synthetic hormones matters, rhythmic dosing is theoretically superior to static dosing, and pharmaceutical economics do shape which treatments get studied. None of that requires accepting the Wiley Protocol as proven, or accepting high-dose untested therapy as safe because the argument for it is compelling. Compelling arguments and proven safety are different things.

    Books Like Sex, Lies, and Menopause

    BookAuthorBest For
    Menopause BootcampSuzanne Gilberg-Lenz, M.D.Evidence-based HRT guidance without the controversy
    The Hormone MythRobyn Stein DeLucaHealthy skepticism about hormone claims
    Hormone IntelligenceAviva Romm, M.D.Integrative balance on women’s hormones
    The Power of HormonesMax NieuwdorpReal endocrinology, accessible and credible
    The Science of MenopauseMary Claire Haver, M.D.Clinical facts, current guidelines